Huron Consulting Group (NASDAQ:HURN) Announces Earnings Results

Huron Consulting Group (NASDAQ:HURN) issued its quarterly earnings data on Tuesday. The business services provider reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.35, Briefing.com reports. The business had revenue of $355.96 million for the quarter, compared to analysts’ expectations of $348.80 million. Huron Consulting Group had a net margin of 4.47% and a return on equity of 17.77%. The business’s revenue was up 12.0% on a year-over-year basis. During the same quarter last year, the company earned $0.87 EPS. Huron Consulting Group updated its FY24 guidance to $5.60-6.10 EPS and its FY 2024 guidance to 5.600-6.100 EPS.

Huron Consulting Group Price Performance

HURN stock traded down $4.70 during midday trading on Wednesday, reaching $88.54. The stock had a trading volume of 93,831 shares, compared to its average volume of 118,385. Huron Consulting Group has a 52-week low of $70.66 and a 52-week high of $113.31. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.61. The company’s fifty day simple moving average is $96.21 and its 200 day simple moving average is $100.59. The company has a market cap of $1.64 billion, a price-to-earnings ratio of 27.33 and a beta of 0.58.

Analysts Set New Price Targets

HURN has been the topic of a number of analyst reports. StockNews.com cut shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a research note on Wednesday, February 28th. Barrington Research lifted their price target on shares of Huron Consulting Group from $128.00 to $133.00 and gave the company an “outperform” rating in a research note on Wednesday, March 6th. Finally, Benchmark reissued a “buy” rating and issued a $140.00 price target on shares of Huron Consulting Group in a research note on Wednesday.

Insider Transactions at Huron Consulting Group

In other news, Director John Mccartney sold 300 shares of Huron Consulting Group stock in a transaction on Monday, April 1st. The stock was sold at an average price of $96.38, for a total transaction of $28,914.00. Following the transaction, the director now owns 56,619 shares in the company, valued at approximately $5,456,939.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director John Mccartney sold 300 shares of Huron Consulting Group stock in a transaction on Monday, April 1st. The stock was sold at an average price of $96.38, for a total transaction of $28,914.00. Following the transaction, the director now owns 56,619 shares in the company, valued at approximately $5,456,939.22. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director James H. Roth sold 2,000 shares of Huron Consulting Group stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $103.22, for a total value of $206,440.00. Following the transaction, the director now owns 68,040 shares in the company, valued at approximately $7,023,088.80. The disclosure for this sale can be found here. Insiders have sold a total of 42,080 shares of company stock worth $4,146,076 in the last quarter. Company insiders own 2.20% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.